Current Issue February 2012, Vol. 163, No. 2

Issue Highlights

Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: The BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
February 2012 (Vol. 163 | No. 2 | Pages 136-141.e1)
Raban Jeger, Matthias Pfisterer, Hannes Alber, Franz Eberli, Søren Galatius, Christoph Naber, Giovanni Pedrazzini, Hans Rickli, Jan Skov Jensen, André Vuilliomenet, Nicole Gilgen, Christoph Kaiser
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
February 2012 (Vol. 163 | No. 2 | Pages 156-163)
Richard M. Steingart, George L. Bakris, Helen X. Chen, Ming-Hui Chen, Thomas Force, S. Percy Ivy, Carl V. Leier, Glenn Liu, Daniel Lenihan, JoAnn Lindenfeld, Michael L. Maitland, Scot C. Remick, W.H. Wilson Tang
Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®
February 2012 (Vol. 163 | No. 2 | Pages 214-221.e1)
Peter Cram, John A. House, John C. Messenger, Robert N. Piana, Phillip A Horwitz, John A. Spertus

Low-dose dobutamine test associated with interventricular dyssynchrony: A useful tool to identify cardiac resynchronization therapy responders: Data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study
20 January 2012
Maurizio Gasparini, Carmine Muto, Saverio Iacopino, Francesco Zanon, Cosimo Dicandia, Giuseppe Distefano, Stefano Favale, Carlo Peraldo Neja, Renato Bragato, Mario Davinelli, Lorenza Mangoni, Alessandra Denaro
Background: Cardiac resynchronization therapy (CRT) is effective in patients with heart failure, but 30% to 50% of subjects are classified as nonresponders. Identifying responders remains a challengin...

View More Articles in Press...

Efficacy of exercise-based cardiac rehabilitation post–myocardial infarction: A systematic review and meta-analysis of randomized controlled trials
October 2011 (Vol. 162 | No. 4 | Pages 571-584.e2)
Patrick R. Lawler, Kristian B. Filion, Mark J. Eisenberg
Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
July 2011 (Vol. 162 | No. 1 | Pages 115-124.e2)
Jeffrey S. Berger, Anuradha Lala, Mori J. Krantz, Gizelle S. Baker, William R. Hiatt
Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis
November 2011 (Vol. 162 | No. 5 | Pages 938-948.e2)
Davide Castagno, Jonathan Baird-Gunning, Pardeep S. Jhund, Giuseppe Biondi-Zoccai, Michael R. MacDonald, Mark C. Petrie, Fiorenzo Gaita, John J.V. McMurray
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
November 2010 (Vol. 160 | No. 5 | Pages 785-794.e10)
SHARP Collaborative Group
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
May 2009 (Vol. 157 | No. 5 | Pages 805-810.e2)
Michael D. Ezekowitz, Stuart Connolly, Amit Parekh, Paul A. Reilly, Jeanne Varrone, Susan Wang, Jonas Oldgren, Ellison Themeles, Lars Wallentin, Salim Yusuf

Most Read lists are compiled every quarter.

On the Cover

New Issue Alert

Free Trial Issue

About American Heart Journal

American Heart Journal has been a trusted resource for cardiologists and general practice physicians for more than 80 years. The Journal focuses its content to respond to the information needs of the cardiology community. In addition to publishing results of important clinical investigations, the Journal addresses such topics as cost-effectiveness, design of clinical trials, reports of negative clinical trials, and the changing organization of medical care.

Impact Factor

2010 Impact Factor* 5.052!
13 out of 114 journals listed
*Journal Citation Reports®, published by Thomson Reuters

Journal Access

Full-text articles and abstracts are available to personal subscribers starting from 1997 to the present; access to abstracts is complimentary. Click here for additional information.

Already have a username and password? Click here to log in.

First-time User? Create an account here.

Institutional subscribers: Click here to access your journal subscription.

Subscribe to the journal now!

American Heart Journal Video Library

Loading Video. Please wait...

The First Call from Dad

Video--flashvideo1ymhj--http://podcasts.elsevierhealth.com/ymhj/ymhj_162_5.flv--/webfiles/images/journals/ymhj/lisa.png

Transradial Angiography and Intervention Focus Issue: Call for Papers

In recognition of the increasing interest and adoption of transradial angiography and intervention, the American Heart Journal will publish a special section dedicated to transradial invasive procedures, in the September 2012 issue. Studies that will be considered for publication include observational analyses or randomized trials that examine technical issues, implementation, or outcomes. Manuscripts should be submitted by June 30, 2012.

To submit your manuscript and for Instructions to Authors, visit http://ees.elsevier.com/ahj/.

For further information, contact Guest Editor Sunil Rao, MD, at sunil.rao@dm.duke.edu.

Access this journal onSciVerse ScienceDirect

Publishing Information

American Heart Journal is published by Elsevier.